A Phase 1, open label, first-in-human study of TR1801-ADC, an antibody drug conjugate (ADC), in patients with select solid tumors expressing c-Met
This Study is
No Longer Enrolling
Details
Locations
University of Colorado Hospital
Study ID
Protocol Number: 19-0232
More information available at ClinicalTrials.gov: NCT03859752
Categories
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers